CSIR, Hyderabad-based pharma firm get regulatory nod for clinical trials on COVID-19 patients with…
New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy…